Table 4 |
|||||||||
|
Simulated crude prevalence odds ratios for fibromyalgia according to hypothesized levels of observed non-differential sensitivity and specificity of outcome misclassification |
|||||||||
|
Specificity |
|||||||||
|
Sensitivity |
100.0% |
99.5% |
99.0% |
98.5% |
98.0% |
97.5% |
97.0% |
96.5% |
96.0% |
|
|
|||||||||
|
100.0% |
3.0 |
3.2 |
3.5 |
3.8 |
4.3 |
5.1 |
6.2 |
8.3 |
13.2 |
|
95.0% |
3.0 |
3.2 |
3.5 |
3.9 |
4.4 |
5.1 |
6.3 |
8.4 |
13.3 |
|
90.0% |
3.0 |
3.2 |
3.5 |
3.9 |
4.4 |
5.1 |
6.3 |
8.4 |
13.4 |
|
85.0% |
3.0 |
3.3 |
3.5 |
3.9 |
4.4 |
5.2 |
6.3 |
8.5 |
13.5 |
|
80.0% |
3.0 |
3.3 |
3.6 |
3.9 |
4.5 |
5.2 |
6.4 |
8.5 |
13.6 |
|
75.0% |
3.1 |
3.3 |
3.6 |
4.0 |
4.5 |
5.3 |
6.4 |
8.6 |
13.7 |
|
70.0% |
3.1 |
3.3 |
3.6 |
4.0 |
4.5 |
5.3 |
6.5 |
8.7 |
13.8 |
|
|
|||||||||
|
Cole et al. BMC Gastroenterology 2006 6:26 doi:10.1186/1471-230X-6-26 |
|||||||||
